The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Klinger Shannon Thyme since 2022.
This trader's CIK number is 1866132.
At the time of last reporting, Klinger Shannon Thyme was the Chief Legal Officer of Moderna, Inc.. (stock ticker symbol MRNA).
Also see all insider trading activities at Moderna, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MRNA | 0 | $0 | 0 | $0 | 11,256 | $0 |
| 2024 | MRNA | 0 | $0 | 10,879 | $1,289,321 | 21,964 | $0 |
| 2023 | MRNA | 0 | $0 | 3,041 | $352,319 | 6,181 | $0 |
| 2022 | MRNA | 0 | $0 | 1,265 | $187,370 | 4,554 | $637,560 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-29 | MRNA | Option Ex | 232 | .00 | 0 |
| 2025-08-27 | MRNA | Option Ex | 774 | .00 | 0 |
| 2025-08-28 | MRNA | Option Ex | 329 | .00 | 0 |
| 2025-06-06 | MRNA | Option Ex | 1,139 | .00 | 0 |
| 2025-05-30 | MRNA | Option Ex | 233 | .00 | 0 |
| 2025-05-28 | MRNA | Option Ex | 328 | .00 | 0 |
| 2025-05-27 | MRNA | Option Ex | 773 | .00 | 0 |
| 2025-03-07 | MRNA | Option Ex | 1,139 | .00 | 0 |
| 2025-02-28 | MRNA | Option Ex | 562 | .00 | 0 |
| 2025-02-27 | MRNA | Option Ex | 5,747 | .00 | 0 |
| 2024-12-09 | MRNA | Sale | 529 | 44.68 | 23,637 |
| 2024-12-06 | MRNA | Option Ex | 1,138 | .00 | 0 |
| 2024-12-02 | MRNA | Option Ex | 232 | .00 | 0 |
| 2024-12-03 | MRNA | Sale | 112 | 43.30 | 4,849 |
| 2024-11-27 | MRNA | Option Ex | 2,981 | .00 | 0 |
| 2024-11-29 | MRNA | Sale | 1,418 | 42.79 | 60,674 |
| 2024-09-06 | MRNA | Option Ex | 1,139 | .00 | 0 |
| 2024-09-09 | MRNA | Sale | 551 | 73.57 | 40,538 |
| 2024-08-30 | MRNA | Option Ex | 233 | .00 | 0 |
| 2024-09-03 | MRNA | Sale | 114 | 76.99 | 8,776 |
| 2024-08-29 | MRNA | Sale | 162 | 78.03 | 12,640 |
| 2024-08-28 | MRNA | Option Ex | 329 | .00 | 0 |
| 2024-06-07 | MRNA | Option Ex | 10,247 | .00 | 0 |
| 2024-06-10 | MRNA | Sale | 5,178 | 148.09 | 766,784 |
| 2024-05-31 | MRNA | Option Ex | 232 | .00 | 0 |
| 2024-06-03 | MRNA | Sale | 122 | 140.72 | 17,167 |
| 2024-05-28 | MRNA | Option Ex | 328 | .00 | 0 |
| 2024-05-29 | MRNA | Sale | 183 | 144.50 | 26,444 |
| 2024-05-28 | MRNA | Sale | 1,296 | 162.47 | 210,566 |
| 2024-05-24 | MRNA | Option Ex | 2,652 | .00 | 0 |
| 2024-03-07 | MRNA | Option Ex | 1,138 | .00 | 0 |
| 2024-03-08 | MRNA | Sale | 544 | 99.05 | 53,883 |
| 2024-02-28 | MRNA | Option Ex | 1,315 | .00 | 0 |
| 2024-02-29 | MRNA | Sale | 670 | 94.57 | 63,363 |
| 2023-12-07 | MRNA | Option Ex | 1,139 | .00 | 0 |
| 2023-12-08 | MRNA | Sale | 563 | 79.08 | 44,524 |
| 2023-12-04 | MRNA | Sale | 111 | 79.31 | 8,803 |
| 2023-12-01 | MRNA | Option Ex | 232 | .00 | 0 |
| 2023-09-07 | MRNA | Option Ex | 1,138 | .00 | 0 |
| 2023-09-08 | MRNA | Sale | 557 | 107.22 | 59,722 |
| 2023-09-01 | MRNA | Option Ex | 233 | .00 | 0 |
| 2023-09-05 | MRNA | Sale | 115 | 111.44 | 12,815 |
| 2023-06-08 | MRNA | Sale | 565 | 124.09 | 70,110 |
| 2023-06-07 | MRNA | Option Ex | 1,139 | .00 | 0 |
| 2023-06-02 | MRNA | Sale | 110 | 130.32 | 14,335 |
| 2023-06-01 | MRNA | Option Ex | 232 | .00 | 0 |
| 2023-03-07 | MRNA | Option Ex | 1,138 | .00 | 0 |
| 2023-03-08 | MRNA | Sale | 561 | 141.51 | 79,387 |
| 2023-03-01 | MRNA | Option Ex | 930 | .00 | 0 |
| 2023-03-02 | MRNA | Sale | 459 | 136.43 | 62,623 |
| 2022-06-07 | MRNA | Option Ex | 4,554 | 140.00 | 637,560 |
| 2022-06-08 | MRNA | Sale | 1,265 | 148.12 | 187,370 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klinger Shannon Thyme (Chief Legal Officer of Moderna, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.